Atyr Pharma Inc (ATYR) Directors and Executive Officers

Officers & Directors

Paul Schimmel
Director

Sara L. Zaknoen
Director

Timothy P. Coughlin
Chairman of the Board

Jane A. Gross
Director

Sanjay S. Shukla, M.D., M.S.
President, Chief Executive Officer and Director (Principal Executive Officer)

Jill M. Broadfoot
Chief Financial Officer

Svetlana Lucas
Director ,

Atyr Pharma Inc currently has 58 employees.

News about Atyr Pharma Inc Key Personnel

aTyr Pharma Strengthens Position in Anti-Fibrotic Research and Oncology with Key Appointments and Promising Therapeutics for Fibrotic Diseases and GBM

In recent months, aTyr Pharma has made significant strides in the development of innovative therapies for complex medical conditions, highlighting its commitment to enhancing treatment outcomes for patients. Central to this momentum is the appointment of Dalia R. Rayes as the Head of Commercial for the Global Efzofitimod Franchise, reflecting a strategic focus on accelerating market penetration and commercial success for the company s promising therapeutics.With a background rich in commercial leadership and extensive industry experience, Rayes emerges as a critical player in aTyr’s future aspirations. Her appointment coincides with the company’s advancing pipeline and represents a pivotal point as aTyr ...